GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Belite Bio Inc (NAS:BLTE) » Definitions » Price-to-Owner-Earnings

BLTE (Belite Bio) Price-to-Owner-Earnings : (As of Sep. 25, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Belite Bio Price-to-Owner-Earnings?

As of today (2024-09-25), Belite Bio's share price is $46.47. Belite Bio does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Belite Bio's Price-to-Owner-Earnings or its related term are showing as below:


BLTE's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 34.02
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-09-25), Belite Bio's share price is $46.47. Belite Bio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $-1.22. Therefore, Belite Bio's PE Ratio for today is At Loss.

As of today (2024-09-25), Belite Bio's share price is $46.47. Belite Bio's EPS without NRI for the trailing twelve months (TTM) ended in was $-1.22. Therefore, Belite Bio's PE Ratio without NRI for today is At Loss.


Belite Bio Price-to-Owner-Earnings Historical Data

The historical data trend for Belite Bio's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belite Bio Price-to-Owner-Earnings Chart

Belite Bio Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
- - - -

Belite Bio Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Belite Bio's Price-to-Owner-Earnings

For the Biotechnology subindustry, Belite Bio's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Belite Bio's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Belite Bio's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Belite Bio's Price-to-Owner-Earnings falls into.



Belite Bio Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Belite Bio's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=46.47/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Belite Bio  (NAS:BLTE) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Belite Bio Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Belite Bio's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Belite Bio Business Description

Traded in Other Exchanges
Address
12750 High Bluff Drive, Suite 475, San Diego, CA, USA, 92130
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Belite Bio Headlines